{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:20:56Z","timestamp":1782296456952,"version":"3.54.5"},"reference-count":56,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170091"],"award-info":[{"award-number":["81170091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373489"],"award-info":[{"award-number":["81373489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81422052"],"award-info":[{"award-number":["81422052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Major Project","award":["2013ZX09509-107"],"award-info":[{"award-number":["2013ZX09509-107"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["13JJ1010"],"award-info":[{"award-number":["13JJ1010"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Hunan Province Educational Department","award":["12K006"],"award-info":[{"award-number":["12K006"]}]},{"name":"Major Program of Changsha Science Project","award":["K1406004-31"],"award-info":[{"award-number":["K1406004-31"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1111\/jcpt.12501","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T12:23:20Z","timestamp":1485951800000},"page":"221-227","source":"Crossref","is-referenced-by-count":21,"title":["Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients"],"prefix":"10.1155","volume":"42","author":[{"given":"Z.-P.","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology; Xiangya Hospital; Central South University; Changsha Hunan China"},{"name":"Hunan Key Laboratory of Pharmacogenetics; Institute of Clinical Pharmacology; Central South University; Changsha Hunan China"},{"name":"Cooperative Innovation Center for Molecular Target New Drug Study; University of South China; Hengyang Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-S.","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.-T.","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.-F.","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-Y.","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology; Xiangya Hospital; Central South University; Changsha Hunan China"},{"name":"Hunan Key Laboratory of Pharmacogenetics; Institute of Clinical Pharmacology; Central South University; Changsha Hunan China"},{"name":"Cooperative Innovation Center for Molecular Target New Drug Study; University of South China; Hengyang Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology; Xiangya Hospital; Central South University; Changsha Hunan China"},{"name":"Hunan Key Laboratory of Pharmacogenetics; Institute of Clinical Pharmacology; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Xiangya Hospital; Central South University; Changsha Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-P.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology; Xiangya Hospital; Central South University; Changsha Hunan China"},{"name":"Hunan Key Laboratory of Pharmacogenetics; Institute of Clinical Pharmacology; Central South University; Changsha Hunan China"},{"name":"Cooperative Innovation Center for Molecular Target New Drug Study; University of South China; Hengyang Hunan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"10.1111\/jcpt.12501-BIB0001|jcpt12501-cit-0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12501-BIB0002|jcpt12501-cit-0002","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archneurol.2010.49","article-title":"Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy","volume":"67","author":"Arif","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1111\/jcpt.12501-BIB0003|jcpt12501-cit-0003","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2710.2007.00831.x","article-title":"Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy","volume":"32","author":"Dutta","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12501-BIB0004|jcpt12501-cit-0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"5","author":"Gugler","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12501-BIB0005|jcpt12501-cit-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-198403000-00001","article-title":"The clinical pharmacology of antiepileptic drugs","volume":"7","author":"Bruni","year":"1984","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/jcpt.12501-BIB0006|jcpt12501-cit-0006","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jcpt.12501-BIB0007|jcpt12501-cit-0007","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","article-title":"Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1111\/jcpt.12501-BIB0008|jcpt12501-cit-0008","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1111\/jcpt.12501-BIB0009|jcpt12501-cit-0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2710.1999.00201.x","article-title":"Clinically significant pharmacokinetic drug interactions between antiepileptic drugs","volume":"24","author":"Tanaka","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12501-BIB0010|jcpt12501-cit-0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/FTD.0000000000000012","article-title":"Influence of uridine diphosphate glucuronosyltransferase 2B7-161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients","volume":"36","author":"Inoue","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12501-BIB0011|jcpt12501-cit-0011","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00007691-199506000-00017","article-title":"Possible interaction between acyclovir and antiepileptic treatment","volume":"17","author":"Parmeggiani","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12501-BIB0012|jcpt12501-cit-0012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eplepsyres.2015.04.015","article-title":"The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients","volume":"114","author":"Sun","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1111\/jcpt.12501-BIB0013|jcpt12501-cit-0013","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","article-title":"Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem","volume":"30","author":"Linden","year":"2007","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12501-BIB0014|jcpt12501-cit-0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijantimicag.2005.09.011","article-title":"Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002)","volume":"27","author":"Masterton","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/jcpt.12501-BIB0015|jcpt12501-cit-0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.diagmicrobio.2006.07.009","article-title":"Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)","volume":"57","author":"Rhomberg","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12501-BIB0016|jcpt12501-cit-0016","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.diagmicrobio.2005.10.001","article-title":"Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004)","volume":"53","author":"Goossens","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12501-BIB0017|jcpt12501-cit-0017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.diagmicrobio.2005.10.006","article-title":"An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997-2004","volume":"53","author":"Jones","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12501-BIB0018|jcpt12501-cit-0018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.diagmicrobio.2005.10.002","article-title":"Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004","volume":"53","author":"Unal","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12501-BIB0019|jcpt12501-cit-0019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jac\/36.suppl_A.207","article-title":"Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem","volume":"36","author":"Norrby","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12501-BIB0020|jcpt12501-cit-0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/sur.2005.6.269","article-title":"Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study","volume":"6","author":"Fabian","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1111\/jcpt.12501-BIB0021|jcpt12501-cit-0021","first-page":"275","article-title":"Empirical monotherapy with meropenem in serious bacterial infections in children","volume":"34","author":"Hsu","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/jcpt.12501-BIB0022|jcpt12501-cit-0022","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1469-0691.2000.00082.x","article-title":"Belgian Multicenter Study Group. Meropenem versus imipenem\/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit","volume":"6","author":"Verwaest","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/jcpt.12501-BIB0023|jcpt12501-cit-0023","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00006454-199907000-00004","article-title":"Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group","volume":"18","author":"Odio","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/jcpt.12501-BIB0024|jcpt12501-cit-0024","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","article-title":"Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study","volume":"49","author":"Haroutiunian","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12501-BIB0025|jcpt12501-cit-0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nrl.2011.03.008","article-title":"Analysis of the valproic acid-meropenem interaction in hospitalised patients","volume":"27","author":"Velez Diaz-Pallares","year":"2012","journal-title":"Neurologia"},{"key":"10.1111\/jcpt.12501-BIB0026|jcpt12501-cit-0026","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2710.2006.00743.x","article-title":"Epileptic seizures caused by low valproic acid levels from an interaction with meropenem","volume":"31","author":"Fudio","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/jcpt.12501-BIB0027|jcpt12501-cit-0027","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1111\/jcpt.12501-BIB0028|jcpt12501-cit-0028","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","article-title":"Meropenem decreases serum level of valproic acid","volume":"31","author":"Nacarkucuk","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1111\/jcpt.12501-BIB0029|jcpt12501-cit-0029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2146\/ajhp050512","article-title":"Meropenem-valproic acid interaction in patients with cefepime-associated status epilepticus","volume":"64","author":"Spriet","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/jcpt.12501-BIB0030|jcpt12501-cit-0030","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"31","author":"Clause","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1111\/jcpt.12501-BIB0031|jcpt12501-cit-0031","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FTD.0b013e318260f7b3","article-title":"Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases","volume":"34","author":"Park","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12501-BIB0032|jcpt12501-cit-0032","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.42.12.3136","article-title":"Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats","volume":"42","author":"Kojima","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12501-BIB0033|jcpt12501-cit-0033","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1211\/0022357011776171","article-title":"Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats","volume":"53","author":"Torii","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1111\/jcpt.12501-BIB0034|jcpt12501-cit-0034","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0378-5173(01)00916-4","article-title":"Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers","volume":"233","author":"Torii","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1111\/jcpt.12501-BIB0035|jcpt12501-cit-0035","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0090-9556(24)15311-1","article-title":"Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats","volume":"27","author":"Yamamura","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jcpt.12501-BIB0036|jcpt12501-cit-0036","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","article-title":"Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats","volume":"32","author":"Nakajima","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jcpt.12501-BIB0037|jcpt12501-cit-0037","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.20338","article-title":"Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human","volume":"94","author":"Omoda","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1111\/jcpt.12501-BIB0038|jcpt12501-cit-0038","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eplepsyres.2006.05.016","article-title":"Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes","volume":"71","author":"Ogawa","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1111\/jcpt.12501-BIB0039|jcpt12501-cit-0039","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1023\/A:1013046229699","article-title":"Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits","volume":"18","author":"Yokogawa","year":"2001","journal-title":"Pharm Res"},{"key":"10.1111\/jcpt.12501-BIB0040|jcpt12501-cit-0040","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1124\/dmd.110.032938","article-title":"Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics","volume":"38","author":"Suzuki","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jcpt.12501-BIB0041|jcpt12501-cit-0041","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/00498254.2011.596582","article-title":"Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid","volume":"41","author":"Suzuki","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1111\/jcpt.12501-BIB0042|jcpt12501-cit-0042","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00498254.2015.1054002","article-title":"In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs","volume":"46","author":"Suzuki","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1111\/jcpt.12501-BIB0043|jcpt12501-cit-0043","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5604\/17322693.1101541","article-title":"Meropenem-therapeutic recommendation after twenty years of presence on pharmaceutical market","volume":"68","author":"Paczkowska","year":"2014","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"10.1111\/jcpt.12501-BIB0044|jcpt12501-cit-0044","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","article-title":"Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin","volume":"42","author":"De Turck","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12501-BIB0045|jcpt12501-cit-0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","article-title":"Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem\/betamipron","volume":"39","author":"Nagai","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12501-BIB0046|jcpt12501-cit-0046","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","article-title":"Meropenem decreases serum level of valproic acid","volume":"31","author":"Nacarkucuk","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1111\/jcpt.12501-BIB0047|jcpt12501-cit-0047","first-page":"258","article-title":"Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics: a discussion of three cases","volume":"27","author":"Llinares Tello","year":"2003","journal-title":"Farm Hosp"},{"issue":"Suppl 2","key":"10.1111\/jcpt.12501-BIB0048|jcpt12501-cit-0048","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1111\/j.1528-1157.1984.tb05644.x","article-title":"Interactions between anticonvulsants and other commonly prescribed drugs","volume":"25","author":"Kutt","year":"1984","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12501-BIB0049|jcpt12501-cit-0049","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3476(82)80204-7","article-title":"The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children","volume":"101","author":"Farrell","year":"1982","journal-title":"J Pediatr"},{"key":"10.1111\/jcpt.12501-BIB0050|jcpt12501-cit-0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2008-1059589","article-title":"Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate","volume":"13","author":"Wolff","year":"1982","journal-title":"Neuropediatrics"},{"key":"10.1111\/jcpt.12501-BIB0051|jcpt12501-cit-0051","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1528-1157.1981.tb06154.x","article-title":"Reduction of steady-state valproate levels by other antiepileptic drugs","volume":"22","author":"Sackellares","year":"1981","journal-title":"Epilepsia"},{"key":"10.1111\/jcpt.12501-BIB0052|jcpt12501-cit-0052","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2217\/pgs-2016-0030","article-title":"Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients","volume":"17","author":"Wen","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1111\/jcpt.12501-BIB0053|jcpt12501-cit-0053","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01964413","article-title":"Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males","volume":"10","author":"Nilsson-Ehle","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12501-BIB0054|jcpt12501-cit-0054","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.37.2.229","article-title":"Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease","volume":"37","author":"Chimata","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12501-BIB0055|jcpt12501-cit-0055","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","article-title":"The effect of carbapenem antibiotics on plasma concentrations of valproic acid","volume":"43","author":"Mancl","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12501-BIB0056|jcpt12501-cit-0056","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/FTD.0000000000000316","article-title":"The effect of different carbapenem antibiotics (ertapenem, imipenem\/cilastatin, and meropenem) on serum valproic acid concentrations","volume":"38","author":"Wu","year":"2016","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12501","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12501\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:35:39Z","timestamp":1749940539000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12501","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}